CME Information

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Radiological Society of North America (RSNA) and the Association of University Radiologists (AUR). The RSNA is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The RSNA designates other activity (blended live and enduring materials) for a maximum of 92.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit is available until July 31, 2021.

Partial CME credit is not available.

Evaluation

Participants must complete an evaluation in order to claim AMA PRA Category 1 CreditTM.

Deadline to evaluate sessions and claim CME credit is Monday, August 16, 2021 at 5:00 PM Eastern.

Target Audience
Radiologists, researchers, or other allied health professionals, trainees, and administrators in academic radiology.

Learning Objectives
At the conclusion of this live activity, participants will be able to:

  • Articulate the elements of professionalism that help maintain the autonomy and leadership role of radiologists in clinical practice.

  • Explain the physician’s professional responsibilities in healthcare, and additional professional responsibilities pertaining to radiologists.

  • Identify how radiologists can detect health disparities and design measures to address them.

  • Describe barriers to access to healthcare and radiology services, and methods to promote health equity.

  • Specify problems affecting the work life of health care providers, including radiology trainees, staff, and faculty.

Disclosures
The Accreditation Council for Continuing Medical Education (ACCME) requires that the Radiological Society of North America (RSNA), as an accredited provider of continuing medical education, obtain signed disclosure statements from meeting faculty, including committee members, program planners, presenters, and authors. The intent of this policy is not to prevent an individual with a financial relationship from participating; however, in accordance with ACCME standards, the RSNA has developed policies and procedures to manage identified conflicts of interest.

The ACCME further requires that the RSNA provide disclosure information to all attendees prior to the educational activity. Individuals who have or have had an affiliation or financial relationship with any commercial interest (within the previous 12 months or at the time the research was conducted) are listed in the program or on the PDF below.

View Program Disclosures.

FDA

This indicates discussion of uses not approved by the FDA. The RSNA and AUR recognize that at educational meetings, faculty may discuss the application of some devices, materials, or pharmaceuticals that are not FDA approved. In keeping with the highest standards of professional integrity and ethics, RSNA and AUR require that faculty fully disclose to their audience that there will be discussion of the unlabeled use of a commercial product, device, or pharmaceutical that has not been approved for such purpose by the FDA.